Trades on 1 secondary market

CTRL Therapeutics

CTRL Therapeutics (cTRL Tx) is a Chicago-based preclinical biotechnology company developing next-generation cell therapies for solid tumors. The company harnesses circulating tumor-reactive lymphocytes (cTRLs) - a rare, potent T cell population found in the blood and naturally equipped to fight canc

minimal 7.7 / 100 0 APIs View provider profile →

Company Biotechnology Cell Therapy Oncology Cancer Healthcare

CTRL Therapeutics is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.